Last reviewed · How we verify
Ketamine high-dose
At a glance
| Generic name | Ketamine high-dose |
|---|---|
| Sponsor | Cedars-Sinai Medical Center |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Ketamine add-on Therapy for Established Status Epilepticus Treatment Trial (KESETT) (PHASE3)
- Anhedonia, Development, and Emotions: Phenotyping and Therapeutics (PHASE4)
- Ketamine Versus Magnesium Sulphate as Adjuvants for ESPB in Breast Cancer Surgery (PHASE2)
- A Study to Evaluate the Efficacy, Safety, and Pharmacokinetic Characteristics of (R)-Ketamine Hydrochloride Nasal Spray in Patients With Depression and Acute Suicidal Ideation or Behavior (PHASE2)
- Intraoperative Multimodal Monitoring as a Means in Reducing the Duration of Mechanical Ventilation in High-Risk Patients Undergoing Major Abdominal Procedures - A Pilot Study (NA)
- Stanford Regulating Circuits of the Brain Study- Ketamine
- Pragmatic Trial of Psilocybin Therapy in Palliative Care (PHASE2)
- The Impact of Propofol and Ketamine on Cardiovascular Collapse During Induction for Intubation
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Ketamine high-dose CI brief — competitive landscape report
- Ketamine high-dose updates RSS · CI watch RSS
- Cedars-Sinai Medical Center portfolio CI